KHR Biotec GmbH
Recorded under 2 name spellings.
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 1 abandoned · 1 no status recorded
Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/874,233 | Novel Ras Inhibitors | Jun 12, 2023 | Pending |
| 18/874,168 | Jun 12, 2023 | No status recorded | |
| 18/874,166 | Novel Ras Inhibitors | Jun 12, 2023 | Pending |
| 18/874,124 | Novel Ras Inhibitors | Jun 12, 2023 | Pending |
| 18/865,113 | Mitoxanthrone Derivatives as Ras Inhibitors | Jun 12, 2023 | Pending |
| 18/686,907 | Novel Ras Inhibitors | Aug 26, 2022 | Pending |
| 17/285,583 | Flavagline Derivatives for Inhibition of Kras Oncogene Activation | Oct 15, 2019 | Abandoned |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built